21 January 2022

Government could tighten controls on opioid 500 times stronger than morphine

21 January 2022

The Government is seeking advice on tightening controls on a deadly opioid that is 500 times stronger than morphine.

Isotonitazene, a synethic opioid that is used instead of or in addition to heroin, has been linked to 25 deaths and seven overdoses up to September 2021, the Home Office said.

Home Secretary Priti Patel has asked the Advisory Council on the Misuse of Drugs (ACMD) for advice on the appropriate classification of Isotonitazene under the Misuse of Drugs Act 1971.

I’m determined to end the misery and destruction caused by the misuse of drugs

She also wants advice on two other substances – CUMYL-PeGACLONE, a synthetic cannabinoid, and Diphenidine, which can have ketamine-like effects.

The three substances are currently covered by the Psychoactive Substances Act 2016, which means that supply, but not possession, is unlawful.

She said: “Reports of fatal overdoses linked to this dangerous substance have been deeply disturbing, and I want to act now to ensure no further lives are lost or families torn apart.

“I’m determined to end the misery and destruction caused by the misuse of drugs and will consider the ACMD’s expert advice on tightening restrictions on this dangerous substance.”

In October last year, the National Crime Agency said it was targeting drug networks that mix Isotonitazene into batches of heroin brought to Britain from Afghanistan.

It came after Public Health England issued a patient safety alert in August, warning of an “unprecedented” number of overdoses potentially caused by heroin mixed with Isotonitazene.

Former ACMD chairman Professor David Nutt, now chairman of the Drug Science Scientific Committee, said: “The rising number of novel opioids and synthetic cannabinoids reflects the cumulation of decades of failed UK drug policy that has demonstrated to all but the willingly blind that the current ban and prosecute approach does not work .

“Worse, it gives the pretence of doing something useful when in reality it distracts from alternative more useful approaches, such as increased treatment and other harm-reduction policies – e.g. safe consumption rooms that have been proven to work in other countries.”

The best videos delivered daily

Watch the stories that matter, right from your inbox